| RS2473808886 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2473809341 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2473810012 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2473810026 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2473810084 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2473810642 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2473811333 |
FOXL2
|
Health Risk |
Likely pathogenic |
— |
| RS2473811785 |
FOXL2
|
Health Risk |
Likely pathogenic |
Blepharophimosis, ptosis |
| RS2473811864 |
FOXL2
|
Health Risk |
Pathogenic |
— |
| RS2473811980 |
FOXL2
|
Health Risk |
Pathogenic |
— |
| RS2473812089 |
FOXL2
|
Health Risk |
Pathogenic |
— |
| RS2473812150 |
FOXL2
|
Health Risk |
Pathogenic |
— |
| RS2473812186 |
FOXL2
|
Health Risk |
Likely pathogenic |
Blepharophimosis, ptosis |
| RS2473812496 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS2473812512 |
FOXL2
|
Health Risk |
Pathogenic |
— |
| RS2473812516 |
FOXL2
|
Health Risk |
Pathogenic |
— |
| RS2473812779 |
FOXL2
|
Health Risk |
Pathogenic |
— |
| RS2473813226 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2473813365 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2473813482 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2473813654 |
FOXL2
|
Health Risk |
Pathogenic |
— |
| RS2473814390 |
FOXL2
|
Health Risk |
Pathogenic |
— |
| RS2473814484 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2473814492 |
FOXL2
|
Health Risk |
Pathogenic |
— |
| RS2473814498 |
FOXL2
|
Health Risk |
Likely pathogenic |
— |
| RS2473814576 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2473814628 |
FOXL2
|
Health Risk |
Pathogenic |
— |
| RS2473814801 |
FOXL2
|
Health Risk |
Likely pathogenic |
Blepharophimosis, ptosis |
| RS2473814910 |
FOXL2
|
Health Risk |
Likely pathogenic |
— |
| RS2473814963 |
FOXL2
|
Health Risk |
Pathogenic |
— |
| RS2473815051 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS2473815062 |
FOXL2
|
Health Risk |
Likely pathogenic |
Blepharophimosis, ptosis |
| RS2473815119 |
FOXL2
|
Health Risk |
Pathogenic |
— |
| RS2473815258 |
FOXL2
|
Health Risk |
Pathogenic |
— |
| RS2473817538 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2473817613 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2473819666 |
P3H2
|
Health Risk |
Likely pathogenic |
— |
| RS2473823658 |
CCDC39
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 14, Primary ciliary dyskinesia 14 |
| RS2473824051 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2473824830 |
CCDC39
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 14, Primary ciliary dyskinesia |
| RS2473824869 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2473825959 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2473826155 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2473826249 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2473826256 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2473828662 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2473828687 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2473828784 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2473830105 |
CACNA1D
|
Health Risk |
Conflicting classifications of pathogenicity |
Aldosterone-producing adenoma with seizures and neurological abnormalities, Aldosterone-producing adenoma with seizures and neurological abnormalities |
| RS2473845881 |
CCDC39
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 14, Primary ciliary dyskinesia 14 |
| RS2473846363 |
ALG3
|
Health Risk |
Pathogenic |
ALG3-congenital disorder of glycosylation, ALG3-congenital disorder of glycosylation |
| RS2473852727 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2473859485 |
ALG3
|
Health Risk |
Pathogenic |
ALG3-congenital disorder of glycosylation, ALG3-congenital disorder of glycosylation |
| RS2473863644 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2473864066 |
COL4A4
|
Health Risk |
Likely pathogenic |
— |
| RS2473864723 |
COL4A4
|
Health Risk |
Likely pathogenic |
COL4A4-related disorder, Autosomal recessive Alport syndrome |
| RS2473865757 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2473875619 |
KNG1
|
Health Risk |
Pathogenic |
High molecular weight kininogen deficiency, High molecular weight kininogen deficiency |
| RS2473882353 |
SLC2A2
|
Health Risk |
Pathogenic |
Fanconi-Bickel syndrome, Fanconi-Bickel syndrome |
| RS2473887956 |
PIK3CA
|
Health Risk |
Likely pathogenic |
Capillary malformation-arteriovenous malformation 1, Capillary malformation-arteriovenous malformation 1 |
| RS2473889192 |
SETD5
|
Health Risk |
Likely pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2473889214 |
SETD5
|
Health Risk |
Likely pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2473889992 |
FGF12
|
Health Risk |
Likely pathogenic |
— |
| RS2473891225 |
SETD5
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2473895350 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2473897094 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2473898987 |
SETD5
|
Health Risk |
Likely pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2473903903 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2473906350 |
SLC2A2
|
Health Risk |
Pathogenic |
Fanconi-Bickel syndrome, Fanconi-Bickel syndrome |
| RS2473906384 |
SLC2A2
|
Health Risk |
Likely pathogenic |
Fanconi-Bickel syndrome, Type 2 diabetes mellitus |
| RS2473916930 |
SLC2A2
|
Health Risk |
Pathogenic |
Fanconi-Bickel syndrome, Fanconi-Bickel syndrome |
| RS2473919563 |
PLD1
|
Health Risk |
Pathogenic |
— |
| RS2473923727 |
SLC2A2
|
Health Risk |
Likely pathogenic |
SLC2A2-related disorder, SLC2A2-related disorder |
| RS2473924536 |
DNAJC19
|
Health Risk |
Likely pathogenic |
3-methylglutaconic aciduria type 5, 3-methylglutaconic aciduria type 5 |
| RS2473926499 |
CACNA1D
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2473927704 |
DNAJC19
|
Health Risk |
Likely pathogenic |
3-methylglutaconic aciduria type 5, 3-methylglutaconic aciduria type 5 |
| RS2473930512 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2473931479 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2473932137 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2473932505 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2473933595 |
DNAJC19
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria type 5, 3-methylglutaconic aciduria type 5 |
| RS2473935158 |
GFM1
|
Health Risk |
Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS2473935333 |
GFM1
|
Health Risk |
Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS2473935676 |
SLC2A2
|
Health Risk |
Likely pathogenic |
SLC2A2-related disorder, SLC2A2-related disorder |
| RS2473937795 |
GFM1
|
Health Risk |
Likely pathogenic |
— |
| RS2473938090 |
GFM1
|
Health Risk |
Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS2473938187 |
GFM1
|
Health Risk |
Pathogenic |
— |
| RS2473938268 |
GFM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS2473938700 |
GFM1
|
Health Risk |
Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS2473938735 |
GFM1
|
Health Risk |
Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS2473938802 |
GFM1
|
Health Risk |
Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS2473939208 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2473939660 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2473939910 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Hematuria |
| RS2473940833 |
GFM1
|
Health Risk |
Likely pathogenic |
— |
| RS2473940889 |
GFM1
|
Health Risk |
Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS2473941549 |
GFM1
|
Health Risk |
Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS2473948725 |
GFM1
|
Health Risk |
Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS2473948919 |
GFM1
|
Health Risk |
Pathogenic |
— |
| RS2473949063 |
GFM1
|
Health Risk |
Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |